The Journal of Phytopharmacology 2026; 15(1):94-98 DOI:10.31254/phyto.2026.15113
Evaluation of anticancer activity of Malus domestica in DMBA-induced breast cancer in rats
Farhat Yasmin1 , Sidhnath Prasad Yadav Deen2 , Shabana Kareem3 , Tushar K. Maiti4 , Pintoo K. Niraj4 , Mohammad Ali5
1. P.G. Department of Biotechnology, Magadh University, Bodh Gaya- 824234, Bihar, India
2. P.G Department of Zoology, Magadh University, Bodh Gaya- 824234, Bihar, India
3. Department of Botany, A. N. College, Patna - 800013, Bihar, India
4. Research Department, Mahavir Cancer Sansthan, Phulwarisharif, Patna- 801505, Bihar, India
5. Senior Scientist, Molecular Diagnostics & Research Lab, Research Department, Mahavir Cancer Sansthan, Phulwarisharif, Patna- 801505, Bihar, India
*Author to whom correspondence should be addressed.
Received: 7th January, 2026 / Accepted: 25th March, 2026 / Published : 30th March, 2026
Background: Breast cancer remains one of the most prevalent malignancies worldwide, with oxidative stress and inflammatory mediators such as TNF-α playing a critical role in tumor progression. Natural products, including Malus domestica (apple), are rich in polyphenols and antioxidants that have shown potential anticancer effects. Therefore, exploring plant-based interventions may provide safer and effective adjunct therapies for the management of breast cancer. The present study has been designed to evaluate the tumor regression properties of apple in a rat model with DMBA-induced mammary tumors. Objective: To evaluate the anticancer activity of M. domestica extract in DMBA-induced breast cancer in rats by assessing tumor regression, oxidative stress markers (LPO), inflammatory marker (TNF-α), hormonal levels, and histopathological changes. Materials and Methods: Female Charles Foster rats were used for the study and mammary tumors were induced by oral administration of 7,12-dimethylbenz[a]anthracene (DMBA) (20 mg/mL) dissolved in olive oil. After tumor development, rats were treated orally with Malus domestica (apple) extract (2 mg/kg body weight) for four weeks. Tumor size was measured to assess regression. Biochemical parameters including lipid peroxidation (LPO), TNF-α, estradiol, and progesterone levels were analyzed. Histopathological examination of mammary tissue was also performed to evaluate cellular changes and therapeutic response. Results: Treatment with M. domestica extract for four weeks resulted in a marked reduction in tumor size (from 1.8 cm to 0.8 cm). A significant decrease (***p < 0.0001) in lipid peroxidation (LPO) and serum TNF-α levels (****p < 0.0001) was observed compared to the DMBA-treated group. Estradiol levels were reduced, while progesterone levels showed no significant change. Histopathological analysis revealed increased apoptosis, reduced mitotic activity, and decreased inflammatory cell infiltration, indicating a positive anticancer effect of the treatment. Conclusion: M. domestica extract exhibits significant anticancer activity in DMBA-induced breast cancer in rats by reducing tumor size, oxidative stress, and inflammatory markers. These findings suggest that apple may serve as a potential adjuvant therapy in the management of breast cancer.
Malus domestica, Breast Cancer, DMBA, Tumor Regression, Oxidative Stress, Apoptosis
HOW TO CITE THIS ARTICLE
Yasmin F, Deen SPY, Kareem S, Maiti TK, Niraj PK, Ali M. Evaluation of anticancer activity of Malus domestica in DMBA-induced breast cancer in rats. J Phytopharmacol 2026; 15(1):94-98. doi: 10.31254/phyto.2026.15113
Creative Commons (CC) License-
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. (http://creativecommons.org/licenses/by/4.0/).
Copyright
Copyright © 2026 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.